Health
Investor Concerns Over Novartis Dealmaking
Novartis investors are increasingly scrutinizing the company's dealmaking strategy following recent setbacks in drug development.
Coverage timeline — 1 article
STAT News
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers and acquisitions
2026-09-11 13:56 UTC